Oliger Christy J. 4

What Happened Christy J. Oliger, a director of Replimune Group, Inc. (REPL), was granted a derivative award for 44,500 shares on April 1, 2026. The Form 4 reports this as an award/acquisition at $0.00 per share (reported total $0). This was an equity grant (award of derivative securities), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; transaction type: Grant/Award (derivative)
• Shares awarded: 44,500; price reported: $0.00; reported value: $0
• Shares owned after transaction: not specified in the filing
• Footnote: The shares underlying this award vest entirely on April 1, 2027.
• Timeliness: The Form 4 was filed late; remark cites an inadvertent administrative error (late filing = L).

Context This filing documents a standard director equity award that vests in one year; it does not represent an immediate purchase or sale of stock. Such grants are commonly used for compensation/retention. The late filing reduces short-term transparency but the issuer has corrected the record by submitting the Form 4.